|
A veteran entrepreneur, Dr. Mostafa Ronaghi has been at the forefront of technological research for over 10 years. He co-founded Pyrosequencing AB, and launched a successful IPO on the Stockholm Stock Exchange in 2000. The genomics company has since acquired three companies and been renamed Biotage. Dr. Ronaghi then co-founded ParAllele BioScience, a company that developed and marketed highly multiplexed technology for genetic testing. ParAllele was acquired by Affymetrix in May of 2005. That same year, Dr. Ronaghi co-founded yet another venture, NextBio. This search engine for life science data is now a viable commercial product.Dr. Ronaghi is currently a principal investigator at Stanford University, focusing on developing novel tools for molecular diagnostics. He earned his Ph.D. from The Royal Institute of Technology, Sweden. Dr. Ronaghi holds more than 20 pending and issued patents and has written more than 50 peer-reviewed publications in journals and books | 